Jeffrey Lipman's Publications

About Jeffrey Lipman's Publications

Honorary Professorial Fellow
  • BENEFITS AND HARMS OF EARLY PROPHYLACTIC INFERIOR VENA CAVA FILTER IN MAJOR TRAUMA PATIENTS: A MULTICENTER RANDOMIZED-CONTROLLED-TRIAL (RCT)

    Date published:
  • The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics

    Advanced Drug Delivery Reviews Date published:
  • A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent

    Journal of Pharmaceutical and Biomedical Analysis Date published:
  • Prevalence of Augmented Renal Clearance and Performance of Glomerular Filtration Estimates in Indigenous Australian Patients Requiring Intensive Care Admission

    Anaesthesia and Intensive Care Date published:
  • Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill

    Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill Date published:
  • Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance

    Intensive Care Medicine Date published:
  • Thank you from HMPG and the editors

    South African Medical Journal Date published:
  • Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

    Critical Care Date published:
  • Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia

    Antimicrobial Agents and Chemotherapy Date published:
  • Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?

    Clinical Pharmacokinetics Date published:
  • Maximally effective dosing regimens of meropenem in patients with septic shock

    Journal of Antimicrobial Chemotherapy Date published:
  • Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections

    Antimicrobial Agents and Chemotherapy Date published:
  • Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition

    Clinical Microbiology and Infection Date published:
  • Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients

    International Journal of Antimicrobial Agents Date published:
  • A validated UHPLC-MS/MS method for the measurement of riluzole in plasma and myocardial tissue samples

    Biomedical Chromatography Date published:
  • Detailed assessment of benefits and risks of retrievable inferior vena cava filters on patients with complicated injuries: the da Vinci multicentre randomised controlled trial study protocol

    BMJ Open Date published: